Clinical trials
Disease clinical trials
Below are recruiting disease clinical trials, each written for real people, not researchers. We’re tracking 9,374 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06535854Recruiting
Comparing heart artery treatments in the Prevail study
This study compares a new treatment for blocked heart arteries with standard care. It aims to see if the new approach is safe and effective for people with chest pain or a recent mild heart attack.
Birmingham, AlabamaAges 18 years+ - NCT06451952Recruiting
Virtual darkness therapy for agitation in dementia
This trial tests whether spending time in a specially designed virtual reality 'darkness' environment can help calm agitation in people with dementia. If you or a loved one often feels restless, anxious, or agitated, this therapy might offer a drug-free way to feel more settled.
Askøy, ErdalAges 50 years+ - NCT06555029Recruiting
Oral health help for older adults on Medicaid
This trial is testing an oral health program offered during routine primary care visits for older adults (55+) on Medicaid. It aims to see if adding dental care support to regular check-ups can improve health.
Cleveland, OhioAges 55 years+ - NCT07870915Recruiting
Body awareness and balance in constipation-predominant irritable bowel syndrome
This study looks at how people with constipation-predominant irritable bowel syndrome (IBS-C) sense their body (called interoception) and how that relates to their balance and posture. It aims to understand if these are different in IBS-C patients compared to people without the condition.
IstanbulAges 18–45 - NCT07405164RecruitingPhase 3
Long-term extension study for people taking belzutifan
This study is for people who are already taking belzutifan in a related trial (LITESPARK-043) and want to continue treatment for advanced solid tumors or von Hippel-Lindau-related conditions. It tests the safety and effects of long-term use.
Boston, MassachusettsAges 18 years+ - NCT07508514Recruiting
Optic nerve sheath changes after therapy in giant cell arteritis
This study looks at how quickly the optic nerve sheath (the protective layer around the eye nerve) changes after starting treatment for giant cell arteritis (GCA), a condition that causes inflammation in blood vessels. It aims to see if these changes can help doctors monitor the disease and guide treatment.
Montreal, QuebecAges 50 years+ - NCT06958107Recruiting
Liquid biopsy study for sarcoma patients
This study uses a simple blood test (liquid biopsy) to look for tiny pieces of tumor DNA in people with sarcoma. It may help doctors learn more about the disease and guide treatment decisions, whether you are just diagnosed, being treated, or have finished treatment recently.
Charlotte, North CarolinaAges Any age - NCT07214571RecruitingPhase 2
Study of S-337395 for RSV in high-risk adults
This trial tests an experimental drug called S-337395 for adults with RSV who are not in the hospital but are at high risk for severe illness. It aims to see if the drug can help prevent symptoms from getting worse.
Los Angeles, CaliforniaAges 18 years+ - NCT05671757RecruitingPhase 1/Phase 2
Daratumumab for primary antiphospholipid syndrome
This early-phase study tests daratumumab, an immune-targeting drug, for people with primary antiphospholipid syndrome (APS). It aims to see whether it can reduce APS activity and improve outcomes while you continue your usual blood-thinning treatment.
Baltimore, MarylandAges 18–65 - NCT06647069RecruitingPhase 1
Testing a new drug for lupus and rheumatoid arthritis
This study tests an investigational drug called SAR448501/DR-0201 in people with active lupus or rheumatoid arthritis who have not responded well to standard treatments. The goal is to see if the drug is safe and helps control disease activity.
Melbourne, VictoriaAges 18–75 - NCT07123519RecruitingPhase 1
YTS109 cell therapy for hard-to-treat autoimmune diseases
This trial tests a new cell therapy called YTS109 for people with certain severe autoimmune diseases that have not responded to standard treatments, such as lupus, Sjögren's syndrome, systemic sclerosis, inflammatory myopathy, vasculitis, and antiphospholipid syndrome. The goal is to see if it can safely reduce disease activity.
TianjinAges 18–65 - NCT07712939RecruitingPhase 1
Study of CND319 for rheumatic diseases
This study tests a new drug called CND319 in healthy volunteers and people with rheumatoid arthritis or Sjögren's disease. The goal is to see if it is safe and how the body responds to it.
Melbourne, VictoriaAges 18–65 - NCT07543367Recruiting
Brain implant to restore arm movement in ALS
This study tests a surgically implanted brain-computer interface (BCI)—a device that reads signals directly from your brain to help control a computer cursor or robotic arm. It's designed for people with ALS whose arms are paralyzed and who haven't responded to standard treatments.
Jacksonville, FloridaAges 22 years+ - NCT07509034RecruitingPhase 1
Targeted immune cells for recurrent small cell lung cancer
This trial tests a special immune cell therapy (CAR T cells) that targets a protein called B7-H3 on your cancer cells. It is for people with small cell lung cancer or similar neuroendocrine cancers that have returned or not responded to standard treatments.
Bethesda, MarylandAges 18–120 - NCT07706686RecruitingPhase 1
Safety and effects of a weakened dengue virus in volunteers
This study tests how the body reacts when volunteers are deliberately infected with a weakened version of the dengue virus. You will be closely monitored and this may help develop better vaccines for dengue.
Bethesda, MarylandAges 18–50 - NCT06615843Recruiting
Digital follow-up after emergency gynecology visit
This study tests a smartphone app to manage follow-up care after a visit to the emergency gynecology department, instead of the usual in-person visits. It aims to make follow-up easier and more convenient for women with certain pregnancy-related or gynecologic conditions.
ParisAges 18–60 - NCT06067451Recruiting
Smart goals for teens with prediabetes
This program helps teens with prediabetes set and reach healthy lifestyle goals. It focuses on weight management and diet changes to help prevent type 2 diabetes.
New York, New YorkAges 10–18 - NCT07883070Recruiting
Screening for anxiety and depression in blood cancer patients
This study looks at how common anxiety and depression are in people with blood cancers. It uses questionnaires to screen your mood, which may help your care team support you better.
Xiamen, FujianAges Any age - NCT07882394Recruiting
Alpha-lipoic acid as an add-on to gum treatment for gingivitis
This trial tests whether adding alpha-lipoic acid (an antioxidant) to standard non-surgical gum treatment helps reduce gingivitis (gum inflammation) better than the standard treatment alone. It aims to see if the combination is more effective for gum health.
IstanbulAges 18–65 - NCT07883499Recruiting
Heart imaging after bypass surgery
This study uses a new type of CT scan to check how well your heart is recovering three months after coronary artery bypass surgery. It aims to see if the scan can detect early problems that might need attention.
BeijingAges 18–100 - NCT07884318Recruiting
Long-term safety study after investigational heart cell treatment
This study looks at the long-term safety of an experimental treatment called JRM-001, which uses a patient's own heart cells to help repair the heart after surgery for congenital heart disease. It is for children who previously took part in an earlier study of this treatment.
Okayama, Okayama-kenAges Any age - NCT07883720Recruiting
Exercise effects on brain health in neurological diseases
This study looks at how exercise might change the body and brain in people with certain neurological disorders compared to healthy people. If you join, you may do some exercise tests and MRI scans, which could help us learn how to improve brain health.
Boston, MassachusettsAges 18 years+ - NCT07875478Recruiting
Tracking health and treatment for people with factor X deficiency
This study collects information from people with factor X deficiency and their family members to better understand how the condition affects people over time. It may help improve future care and treatment.
FlorenceAges Any age - NCT07883044Recruiting
Gut bacteria supplement for mild Crohn's disease
This trial tests a specially formulated supplement (sodium propionate) to see if it can improve the balance of bacteria in your gut, which may help control Crohn's disease. It's for people with mild or inactive Crohn's who want to explore a new way to support their gut health.
PadovaAges 18–75
Hear when a new Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for disease?
- Yes. Clin2 currently lists 9,374 recruiting disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.